United States v. Nna Onuoha , 686 F. App'x 401 ( 2017 )


Menu:
  •                                                                             FILED
    NOT FOR PUBLICATION
    MAR 31 2017
    UNITED STATES COURT OF APPEALS                       MOLLY C. DWYER, CLERK
    U.S. COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    UNITED STATES OF AMERICA,                        No.   16-50399
    Plaintiff-Appellee,                D.C. No.
    2:13-cr-00676-BRO-1
    v.
    NNA ALPHA ONUOHA, AKA Naa                        MEMORANDUM*
    Alpha Onuoha,
    Defendant-Appellant.
    Appeal from the United States District Court
    for the Central District of California
    Beverly Reid O’Connell, District Judge, Presiding
    Submitted February 24, 2017**
    San Francisco, California
    Before: GOULD and BERZON, Circuit Judges, and STEEH,*** District Judge.
    *
    This disposition is not appropriate for publication and is not precedent
    except as provided by Ninth Circuit Rule 36-3.
    **
    The panel unanimously concludes this case is suitable for decision
    without oral argument. See Fed. R. App. P. 34(a)(2).
    ***
    The Honorable George Caram Steeh III, United States District Judge
    for the Eastern District of Michigan, sitting by designation.
    Defendant-Appellant Nna Onuoha appeals the district court’s order granting
    the Government’s request to involuntarily administer psychotropic medication
    under Sell v. United States, 
    539 U.S. 166
    (2003). This is Onuoha’s second appeal
    of an order by the district court permitting involuntary medication. In the first
    appeal, we vacated the district court’s order and remanded on an open record. See
    United States v. Onuoha, 
    820 F.3d 1049
    , 1060 (9th Cir. 2016). We held that the
    first Sell factor—whether important governmental interests are at stake in
    prosecuting the defendant for the charged offense—was satisfied, but that the
    fourth Sell factor—whether the proposed treatment plan was in the patient’s best
    medical interests in light of his medical condition—was not satisfied. See 
    id. at 1054.
    On remand, the district court held a hearing and again granted the
    Government’s Sell motion. We have jurisdiction under 28 U.S.C § 1291, and we
    affirm.
    Onuoha challenges the district court’s second Sell order only as to the first
    factor. Whether this factor is met is primarily a legal question, so we review it de
    novo. United States v. Ruiz-Gaxiola, 
    623 F.3d 684
    , 693 (9th Cir. 2010). Onuoha
    contends that while his offense was “serious” enough to support an important
    governmental interest in prosecution, his offense’s Sentencing Guidelines range of
    27 to 33 months makes it less serious than other “serious” offenses that can satisfy
    2
    the first Sell factor. We recognized in our prior opinion that 27 to 33 months “is
    lower than any range we have previously held to be indicative of a ‘serious’ crime
    under the first Sell factor.” 
    Onuoha, 820 F.3d at 1055
    . But we also made clear
    that “the Guidelines range is only the starting point in determining whether the
    government has an important interest in prosecution.” 
    Id. We placed
    heavy
    emphasis on the fact that Onuoha’s actions were reasonably perceived as threats of
    terrorism, and that they necessitated a significant security response. See 
    id. These considerations
    outweighed the relatively low Guidelines range. See 
    id. at 1055–56.
    Onuoha has not persuaded us that we should consider these interests differently
    now.
    Onuoha next argues that the time he has spent in custody since his arrest
    mitigates the Government’s interest in prosecution. It is true that Onuoha has been
    in federal custody since September 11, 2013. At the time of our earlier decision,
    Onuoha had served longer than the minimum Guidelines range of 27 months. 
    Id. at 1056.
    He has now served above the Guidelines maximum of 33 months. But
    even if Onuoha’s additional time in custody tends to lessen the Government’s
    interest in prosecution, see 
    Sell, 539 U.S. at 180
    , nonetheless it does not nullify that
    important interest. As explained in our earlier opinion, the Government’s interest
    in obtaining a conviction extends not only to incapacitating Onuoha, but also to
    3
    deterring others from making similar threats. 
    Onuoha, 820 F.3d at 1056
    –57. This
    interest in general deterrence holds firm regardless of the length of Onuoha’s
    pretrial detention. We note that generally deterring others from making threats of
    violence related to the nation’s transportation infrastructure remains an important
    goal for society.
    There is a separate reason beyond gaining conviction and deterring others
    for concluding that important governmental interests are at stake. With a
    conviction comes the possibility of supervised release, which may be critical to
    preventing Onuoha from making similar threats in the future. See 
    id. at 1056.
    Prosecuting Onuoha thus benefits not only society but possibly Onuoha himself,
    who without supervision may become embroiled in another such controversy.
    Finally, Onuoha asserts that the Government’s interest in prosecution is
    mitigated because his offense was a product of his mental illness. There is support
    in the record for the notion that Onuoha’s threats were driven, at least in part, by
    mental illness. And “the fact that a defendant’s mental disorder contributed to his
    offense may weaken the government’s interest in prosecuting him.” United States
    v. Gillenwater, 
    749 F.3d 1094
    , 1102 (9th Cir. 2014). However, in certain cases,
    “the link between [a defendant’s] mental disorder and his charged crimes makes
    his prosecution all the more important.” 
    Id. That appears
    to be the case here,
    4
    where absent prosecution and treatment, there is a risk Onuoha may repeat similar
    threats in the future.
    We conclude that the district court did not err in holding that the
    Government met its burden on the first Sell factor.
    AFFIRMED.
    5
    

Document Info

Docket Number: 16-50399

Citation Numbers: 686 F. App'x 401

Filed Date: 3/31/2017

Precedential Status: Non-Precedential

Modified Date: 1/13/2023